BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Safer Lock Release: City of Citrus Heights Offers Free Safer Locks to Protect Residents From Accidental Poisonings and Addiction

  In a ground-breaking program designed to prevent accidental poisoning and addiction, the City of Citrus Heights, California, will provide 1,000 Safer Lock prescription bottles with locking caps to Citrus Heights parents.

  December 27, 2017

   · 

  3 min read
• Policy

  Eisai: Anticancer Agent Lenvatinib Designated for Priority Review and Approval by CFDA for Hepatocellular Carcinoma

  The Priority Review and Approval procedure was implemented by the CFDA in February 2016 with the aim of accelerating research, development and launch of new medicines that have significant clinical value.

  December 27, 2017

   · 

  4 min read
• Business

  HTG Molecular Diagnostics Expands its Collaboration With Merck KGaA, Darmstadt, Germany

  The Master Collaboration Agreement complements the previously announced Master Companion Diagnostic Agreement with Merck KGaA.

  December 27, 2017

   · 

  4 min read
• Rezolute Enters Into Common Stock Purchase Agreement for Up to $10M With Lincoln Park Capital Fund, LLC

  Proceeds from the Agreement will be used for operations and to advance the development of Rezolute’s product candidates and product collaborations.

  December 27, 2017

   · 

  4 min read
• 

  Drug Development

  Sarepta Shows Off Long-Term Pulmonary Function of Eteplirsen-Treated DMD Patients

  A statistically significant and clinically meaningful reduction in pulmonary decline was observed for the eteplirsen-treated patients.

  December 27, 2017

   · 

  6 min read
• Drug Development

  Diffusion Pharmaceuticals Begins Phase III Clinical Trial With TSC in Glioblastoma Multiforme

  The trial will screen 300 patients and enroll 264 in an effort to ensure that results from 236 patients will be available for analysis.

  December 27, 2017

   · 

  10 min read
• Drug Development

  Athenex Receives Promising Innovative Medicine Designation From the United Kingdom MHRA for Oraxol, An Innovative Oral Form of Paclitaxel

  The existing marketed form of paclitaxel can only be administered intravenously.

  December 27, 2017

   · 

  6 min read
• Drug Development

  Innovation Pharmaceuticals Obtains Direct Evidence of Molecular Pathways Modulation in Tumors From First Patients in Kevetrin PhIIa Ovarian Cancer Trial

  The findings confirm in patient tumors Kevetrin-induced anti-cancer effects similar to those demonstrated (pdf) preclinically in ovarian cancer cell-lines.

  December 27, 2017

   · 

  9 min read
• Drug Development

  Actinium Pharmaceuticals Provides Update on Pivotal Phase III Trial of Iomab-B: Independent Data Monitoring Committee Recommends SIERRA Trial Continue

  Actinium expects enhanced awareness of Iomab-B at ASH annual meeting and expanded site activity to enable completion of trial enrollment by end of 2018, in-line with prior forecast.

  December 27, 2017

   · 

  10 min read
• Biotech Bay

  Biotricity Closes a Registered Direct Financing and Paves the Way for Bioflux Launch

  The gross proceeds from the offering will be approximately $2.5M before deducting estimated offering expenses.

  December 27, 2017

   · 

  5 min read